Skip to Content

Aeolus Pharmaceuticals Inc AOLS

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AOLS is trading at a 39% discount.
Price
$0.00
Fair Value
$2.57
Uncertainty
Extreme
1-Star Price
$7.83
5-Star Price
$7.14
Economic Moat
Wjnjftb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AOLS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$15,208.58
Volume/Avg
887 / 18,804

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

Aeolus Pharmaceuticals Inc is a Southern California based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
4

Valuation

Metric
AOLS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AOLS
Quick Ratio
1.22
Current Ratio
1.30
Interest Coverage
Quick Ratio
AOLS

Profitability

Metric
AOLS
Return on Assets (Normalized)
−143.67%
Return on Equity (Normalized)
−188.68%
Return on Invested Capital (Normalized)
−188.68%
Return on Assets
AOLS

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AJjsk$82.2 Bil
MKKGY
Merck KGaA ADRFvrsvy$75.8 Bil
HLN
Haleon PLC ADRMtd$38.8 Bil
RDY
Dr Reddy's Laboratories Ltd ADRKbsw$11.5 Bil
VTRS
Viatris IncMrch$11.2 Bil
CTLT
Catalent IncCkbwgk$7.2 Bil
PRGO
Perrigo Co PLCQwfts$4.2 Bil
PBH
Prestige Consumer Healthcare IncBsvvz$2.9 Bil
CURLF
Curaleaf Holdings IncLrz$2.6 Bil
GTBIF
Green Thumb Industries IncRmk$2.5 Bil